ACT NOW Longitudinal Study: Outcomes of Babies With Opioid Exposure Study
Sponsored by Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program
About this trial
Last updated 2 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended 2 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Exposed infants: Born ≥37 weeks gestation with second or third trimester opioid exposure
- Control infants: Born ≥37 weeks gestation with no antenatal drug exposure
Exclusion Criteria
1. Infants with known chromosomal or congenital anomalies potentially affecting the central nervous system
2. Apgar score at 5 minutes of <5
3. Any requirement for positive pressure ventilation in the NICU
4. Inability to return for outpatient MRI and/or follow-up
5. IUGR <3rd percentile
6. Heavy alcohol use during pregnancy (8+ drinks per week).